CORRADINI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 502
EU - Europa 186
AS - Asia 73
OC - Oceania 4
SA - Sud America 2
AF - Africa 1
Totale 768
Nazione #
US - Stati Uniti d'America 499
RU - Federazione Russa 81
IT - Italia 37
IE - Irlanda 22
HK - Hong Kong 20
CN - Cina 18
SG - Singapore 16
DE - Germania 12
SE - Svezia 11
GB - Regno Unito 7
IN - India 7
FI - Finlandia 6
AU - Australia 4
BE - Belgio 4
CA - Canada 3
KR - Corea 3
BR - Brasile 2
ID - Indonesia 2
NL - Olanda 2
PH - Filippine 2
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GE - Georgia 1
RO - Romania 1
TH - Thailandia 1
TJ - Tagikistan 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 768
Città #
Santa Clara 188
Fairfield 54
Ann Arbor 34
Woodbridge 31
Cambridge 26
Dublin 22
Ashburn 20
Seattle 18
Houston 17
Chandler 16
Hong Kong 14
Singapore 14
Wilmington 14
Beijing 8
Moscow 7
Mumbai 7
Princeton 7
Munich 6
Bologna 5
Lawrence 5
Altamura 4
Boston 4
Brussels 4
Florence 4
Helsinki 4
Melbourne 4
Shanghai 4
Chicago 3
Falkenstein 3
Gangdong-gu 3
Pisa 3
Rozzano 3
Boardman 2
Falls Church 2
Hounslow 2
Jakarta 2
Milan 2
Montecatini Terme 2
New York 2
Salerno 2
San Diego 2
Santa Maria 2
Thiene 2
Toronto 2
Verona 2
Abidjan 1
Bangkok 1
Bern 1
Bollate 1
Buffalo 1
Chongqing 1
Dearborn 1
Genzano Di Roma 1
Grosseto 1
Guangzhou 1
Izmir 1
Jacksonville 1
Kamloops 1
Kent 1
London 1
Medford 1
Mogilëv 1
Nuremberg 1
Padova 1
Redmond 1
Romola 1
Salvador 1
Washington 1
Yiwu 1
Yubileyny 1
Totale 607
Nome #
RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI 162
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 159
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR 133
Safety Profile of Idelalisib in Patients with Refractory Follicular Lymphoma: Interim Analysis of a Noninterventional Study 129
Experts' considerations on HLA-haploidentical stem cell transplantation 121
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 74
Totale 778
Categoria #
all - tutte 2.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 15 13 14 4 9 2
2020/202174 4 6 6 3 0 0 6 9 9 9 11 11
2021/202240 1 2 6 1 4 1 2 1 7 0 3 12
2022/202389 11 10 7 7 8 16 12 8 6 1 2 1
2023/202476 3 7 12 2 8 10 8 10 4 6 3 3
2024/2025346 12 29 19 56 130 100 0 0 0 0 0 0
Totale 778